Physician profile
Katelyn Beilby
NPI 1376363978
$1,159.98
in general payments reported to CMS, 2019-2025
10 companies · $885 in 2025
The $885 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $275 · 2025: $885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083 · Education: $76.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.34 |
| Education | $76.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $257.77 | 2024-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $249.66 | 2024-2025 | |
| Genzyme Corporation | $133.84 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $125.00 | 2025 | Cabtreo |
| Galderma Laboratories, L.P. | $124.81 | 2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $100.73 | 2024-2025 | Dupixent |
| Lilly USA, LLC | $67.16 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Amgen INC. | $45.93 | 2025 | Otezla |
| Ucb, INC. | $39.27 | 2025 | Bimzelx |
| Biowound Solutions, INC. | $15.81 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Beilby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.